Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C in pregnancy.

Sangeeta Jain1, Nima Goharkhay, George Saade

  • 1Division of Maternal Fetal Medicine, Department of Obstretics and Gynecology, University of Texas, Medical Branch, Galveston, Texas 77555-0587, USA.

American Journal of Perinatology
|April 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial Differences in Adverse Pregnancy Outcomes and Incident Hypertension: A Mediation Analysis.

Journal of the American Heart Association·2026
Same author

Prenatal exposure to nicotine and postpartum depression: a systematic review and meta-analysis.

Archives of women's mental health·2026
Same author

L-Citrulline in Maternal-Fetal and Neonatal Health: Metabolic Mechanisms and Emerging Therapeutic Applications.

Nutrients·2026
Same author

Mediating effect of social determinants of health between race and phthalate biomarkers in pregnancy.

Pregnancy (Hoboken, N.J.)·2026
Same author

The Influence of Hindsight and Outcome Bias on Fetal Heart Rate Interpretation and Judgments of Obstetric Care Quality.

American journal of perinatology·2026
Same author

Severe Maternal Morbidity and Breastfeeding Among Nulliparous Individuals in the United States.

Obstetrics and gynecology·2026
Same journal

Regenerative Cell and Cell-Free Therapies for Necrotizing Enterocolitis: Progress Toward Clinical Translation.

American journal of perinatology·2026
Same journal

WIC Participation and the Education-related Gap in Adverse Neonatal Outcomes: A Population-based Cohort Study.

American journal of perinatology·2026
Same journal

Low-Dose Aspirin Prophylaxis for Preeclampsia and the Risk of Postpartum Hypertensive Outcomes: A Propensity Score Analysis.

American journal of perinatology·2026
Same journal

Cystic Periventricular Leukomalacia in Preterm Infants: Clinical Risks, Heart Rate, and Oxygenation Patterns.

American journal of perinatology·2026
Same journal

International Consensus Curriculum and Competency Framework for Maternal Point-of-Care Ultrasound Training.

American journal of perinatology·2026
Same journal

From InSurE to MIST: A Quality Improvement Initiative in a Level IV NICU.

American journal of perinatology·2026
See all related articles

Hepatitis C virus (HCV) is a leading cause of chronic liver disease. Maternal-fetal transmission is a significant concern, especially in co-infected women, with treatment contraindicated during pregnancy.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C is a primary cause of chronic liver disease and liver transplantation in the US.
  • Transfusion-related Hepatitis C virus (HCV) transmission has been minimized through blood product screening.
  • Maternal-fetal transmission is now a predominant route of HCV infection.

Purpose of the Study:

  • To provide an updated review of Hepatitis C virus (HCV).
  • To discuss disease agent, risk factors, transmission, diagnosis, and treatment.
  • To evaluate perinatal issues related to HCV.

Main Methods:

  • Literature review of Hepatitis C virus (HCV).
  • Analysis of epidemiological data on HCV transmission.
  • Review of current diagnostic and treatment modalities for HCV.

Related Experiment Videos

Main Results:

  • HCV is a major cause of chronic liver disease and liver transplantation.
  • Maternal-fetal transmission is a key transmission route, particularly in HIV-coinfected women.
  • HCV treatment during pregnancy is not recommended, despite increased chronic liver disease risk from perinatal transmission.

Conclusions:

  • Hepatitis C virus (HCV) remains a significant public health concern.
  • Further evaluation of perinatal transmission and management is necessary.
  • Understanding risk factors and transmission is crucial for prevention and control.